Company News
eXoZymes Gets $2M NIH Grant, Shares Up
eXoZymes Inc shares jumped 3.9% in after‑hours trading after receiving a $2.028 million NIH SBIR Phase IIB grant.
The grant provides $1.034 million for year one and $994,000 for year two, bringing tot
